Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

VNLS

Vernalis (VNLS)

Vernalis Plc ADS (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VNLS
DateTimeSourceHeadlineSymbolCompany
12/11/20062:00AMPR Newswire (US)Vernalis plc Initiates a Phase I Trial of a Promising New Approach to Treating Obesity and Related Disorders - Including Type IINASDAQ:VNLS
11/21/20062:00AMPR Newswire (US)Vernalis plc to Present at the 18th Annual Piper Jaffray Healthcare Conference in New York on November 30, 2006NASDAQ:VNLSVernalis Plc ADS (MM)
11/20/20062:00AMPR Newswire (US)Vernalis plc Announces Progress on Its Oncology Hsp90 ProgrammeNASDAQ:VNLS
11/02/20062:00AMPR Newswire (US)Vernalis to Present at Cowen and Company 7th Annual Global Health Care ConferenceNASDAQ:VNLS
09/20/20069:31AMPR Newswire (US)Vernalis plc to Present at UBS Global Life Sciences Conference on September 26, 2006NASDAQ:VNLSVernalis Plc ADS (MM)
09/20/20066:30AMPR Newswire (US)Vernalis plc Announces FDA Acceptance for Filing of Frova(R) for Short-Term Prevention of Menstrual MigraineNASDAQ:VNLS
09/12/20063:00AMPR Newswire (US)Vernalis Plc: Interim Results for the Six Months Ended 30 June 2006NASDAQ:VNLS
07/19/20066:00PMPR Newswire (US)Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of MenNASDAQ:VNLSVernalis Plc ADS (MM)
07/19/20066:00PMPR Newswire (US)Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of MenNASDAQ:VNLS
06/19/20067:00AMPR Newswire (US)Vernalis plc to Present at Investor Conferences During June 2006NASDAQ:VNLSVernalis Plc ADS (MM)
05/17/20061:00PMPR Newswire (US)Vernalis plc [VNLS] CEO to Ring the NASDAQ Stock Market Closing BellNASDAQ:VNLSVernalis Plc ADS (MM)
05/15/20063:00AMPR Newswire (US)Vernalis plc to Ring the NASDAQ Closing Bell on May 18, 2006NASDAQ:VNLS
05/08/20063:00AMPR Newswire (US)Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual MigraineNASDAQ:VNLS
07/14/20046:50PMPR Newswire (US)Endo Licenses Rights from Vernalis to Market Acute Migraine Treatment Frova(TM)NASDAQ:VNLS
03/30/20047:00AMPR Newswire (US)Vernalis Regains Control of North American Rights To Frovatriptan From ElanNASDAQ:VNLSVernalis Plc ADS (MM)
03/30/20047:00AMPR Newswire (US)Vernalis plc: Preliminary Results for the Eight Months Ended 31 December 2003NASDAQ:VNLS
 Showing the most relevant articles for your search:NASDAQ:VNLS

Your Recent History

Delayed Upgrade Clock